Targeting NCAM1/FGFR1 Signaling to Alleviate Sleep Disturbance-Induced Neuroinflammation in the Hypothalamus
Cells · 2026
DOI: 10.3390/cells15181716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Yanxiang Qu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Forensics, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Hypothalamus, Signal Transduction, Neuroinflammatory Diseases. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China (2022YFA1604503), Foundation of State Key Laboratory of Space Medicine, China Astronaut Research and Training Center.
Themen: Schlaf
Abstract (Originalsprache)
Sleep disturbance is a prevalent public health concern associated with cognitive deficits and emotional dysregulation, yet the mechanisms underlying SD-induced hypothalamic dysfunction remain incompletely understood. Here, we found that two weeks of SD induced marked hypothalamic neuroinflammation, accompanied by increased expression of the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, as well as the chemokine Ccl2, together with reduced neuronal markers, including decreased Nissl-body and NeuN+ cells. Single-nucleus RNA sequencing (snRNA-seq) suggested that inhibitory neurons exhibited prominent transcriptional responses to SD, including enrichment of inflammatory pathways such as TNF and IL-17 signaling and transcriptional programs associated with neuronal dysfunction. Furthermore, SD was also associated with microglial activation and a phenotypic shift toward a disease-associated state, exhibiting enhanced antigen-presenting and pro-inflammatory capacity. Notably, intercellular communication analysis identified the neural cell adhesion molecule 1 (NCAM1)/fibroblast growth factor receptor 1 (FGFR1) signaling axis as a key mediator of crosstalk between microglia and other cell types. In BV2 cells, recombinant NCAM1 attenuated lipopolysaccharide-induced inflammatory responses in an Fgfr1-dependent manner. Consistently, PVN-targeted Fgfr1 knockdown in vivo exacerbated SD-associated microglial activation, neuroinflammation, and neuronal injury. Collectively, our findings elucidate a critical protective role for the NCAM1/FGFR1 axis in mitigating SD-induced hypothalamic neuroinflammation and neuronal injury. This highlights this pathway as a candidate mechanism for further therapeutic investigation in sleep-related neurological dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Forensics, Dalian Medical University, Dalian 116044, China.
- State Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing 100094, China.
ORCID-Profile: Kai Li, Xiaopeng Li, Lina Qu
Förderung
- National Key R&D Program of China (2022YFA1604503)
- Foundation of State Key Laboratory of Space Medicine, China Astronaut Research and Training Center
Zitieren
APA
Qu, Y., Li, B., Yan, S., Zhang, C., Ji, G., Li, K., Zhao, Y., Wang, Z., Li, X., Song, B., & Qu, L. (2026). Targeting NCAM1/FGFR1 Signaling to Alleviate Sleep Disturbance-Induced Neuroinflammation in the Hypothalamus. Cells. https://doi.org/10.3390/cells15181716
Vancouver
Qu Y, Li B, Yan S, Zhang C, Ji G, Li K, et al. Targeting NCAM1/FGFR1 Signaling to Alleviate Sleep Disturbance-Induced Neuroinflammation in the Hypothalamus. Cells. 2026. doi:10.3390/cells15181716
BibTeX
@article{Qu2026,
author = {Qu, Yanxiang and Li, Bo and Yan, Shixuan and Zhang, Chuanjie and Ji, Guohua and Li, Kai and Zhao, Yujie and Wang, Zuoyang and Li, Xiaopeng and Song, Bo and Qu, Lina},
title = {Targeting NCAM1/FGFR1 Signaling to Alleviate Sleep Disturbance-Induced Neuroinflammation in the Hypothalamus},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181716}
}
EUVIMED